DOBMEIER ERIC 4

What Happened Eric Dobmeier, a director of Structure Therapeutics, received an equity award on 2026-06-17 covering 39,453 Ordinary Shares (reported as a derivative award). The filing shows an acquisition price of $0.00 at grant (no cash paid at grant); a related footnote states the option exercise price per share will equal the fair market value per Ordinary Share based on the Issuer's ADS trading price on the grant date.

Key Details

• Transaction date: 2026-06-17 (Form 4 filed 2026-06-18, timely).
• Award size: 39,453 Ordinary Shares (derivative). Equivalent to about 13,151 ADSs (each ADS = 3 Ordinary Shares).
• Reported acquisition price at grant: $0.00 (derivative award); footnote indicates exercise price will equal FMV based on ADS price.
• Vesting: equal monthly installments over the 12 months following June 17, 2026; grant will be fully vested by the day before the 2027 annual meeting.
• Shares owned after transaction: not specified in the provided excerpt of the Form 4.
• Filing timeliness: appears timely (filed one day after the transaction).

Context This was an equity award (derivative grant/options-style award), not a sale or cash purchase. The award does not indicate immediate sale of shares — vesting and any later exercise/sale would be reported in future filings. The ADS conversion note (3 Ordinary Shares per ADS) is relevant if you track holdings by ADSs rather than Ordinary Shares.